Golubev D S, Komkov D S, Shepelev M V, Mazurov D V, Kruglova N A
Center of Precision Genome Editing and Genetic Technologies for Biomedicine, Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334 Russia.
Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Be'erSheva, 8410501 Israel.
Mol Biol (Mosk). 2024 Jul-Aug;58(4):575-589.
The low knock-in efficiency, especially in primary human cells, limits the use of the genome editing technology for therapeutic purposes, rendering it important to develop approaches for increasing the knock-in levels. In this work, the efficiencies of several approaches were studied using a model of knock-in of a construct coding for the peptide HIV fusion inhibitor MT-C34 into the human CXCR4 locus in the CEM/R5 T cell line. First, donor DNA modification was evaluated as a means to improve the efficiency of plasmid transport into the nucleus. The donor plasmid was modified to include the simian virus 40 (SV40) DNA nuclear targeting sequence (DTS) or binding sites for the transcription factor NF-κB, whose effects on the knock-in levels have not been described. The modification was ineffective in the model of MT-C34 knock-in into the CXCR4 locus. A second approach consisted in modification of Cas9 nuclease by introducing two additional nuclear localization signals (NLSs) and increased the knock-in level by 30%. Finally, blocking DNA repair via the nonhomologous end joining (NHEJ) pathway with DNA-dependent protein kinase inhibitors caused a 1.8-fold increase in knock-in. A combination of the last two approaches caused an additive effect. Thus, increasing the number of NLSs in the Cas9 protein and inhibiting DNA repair via the NHEJ pathway significantly increased the level of knock-in of the HIV-1 fusion inhibitory peptide into the clinically relevant locus CXCR4. The finding can be used to develop effective gene therapy approaches for treating HIV infection.
低敲入效率,尤其是在原代人类细胞中,限制了基因组编辑技术在治疗目的上的应用,因此开发提高敲入水平的方法变得很重要。在这项工作中,使用将编码肽HIV融合抑制剂MT-C34的构建体敲入CEM/R5 T细胞系中的人类CXCR4基因座的模型,研究了几种方法的效率。首先,评估供体DNA修饰作为提高质粒转运到细胞核效率的一种手段。供体质粒被修饰以包含猿猴病毒40(SV40)DNA核靶向序列(DTS)或转录因子NF-κB的结合位点,其对敲入水平的影响尚未见报道。这种修饰在MT-C34敲入CXCR4基因座的模型中无效。第二种方法是通过引入两个额外的核定位信号(NLSs)来修饰Cas9核酸酶,并使敲入水平提高了30%。最后,用DNA依赖性蛋白激酶抑制剂通过非同源末端连接(NHEJ)途径阻断DNA修复,使敲入增加了1.8倍。最后两种方法的组合产生了累加效应。因此,增加Cas9蛋白中的NLSs数量并通过NHEJ途径抑制DNA修复,可显著提高HIV-1融合抑制肽敲入临床相关基因座CXCR4的水平。这一发现可用于开发治疗HIV感染的有效基因治疗方法。